Viburcol, Engystol, Lymphomyosot - Bioregulatory Approach in Pediatric Practice

One of the most urgent problems in modern pediatrics and neonatology is the need for drugs, which, along with proven efficacy, also will be maximum safe for a growing child's body. The article presents an overview of publications on clinical studies of combined bioregulatory drugs (CBD) ­Viburc...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yazar: S.V. Popovych (Yazar)
Materyal Türü: Kitap
Baskı/Yayın Bilgisi: Zaslavsky O.Yu., 2016-09-01T00:00:00Z.
Konular:
Online Erişim:Connect to this object online.
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_d2ef2c07aaad4e18bcc9c8037b3e0e62
042 |a dc 
100 1 0 |a S.V. Popovych  |e author 
245 0 0 |a Viburcol, Engystol, Lymphomyosot - Bioregulatory Approach in Pediatric Practice 
260 |b Zaslavsky O.Yu.,   |c 2016-09-01T00:00:00Z. 
500 |a 2224-0551 
500 |a 2307-1168 
500 |a 10.22141/2224-0551.6.74.2016.82131 
520 |a One of the most urgent problems in modern pediatrics and neonatology is the need for drugs, which, along with proven efficacy, also will be maximum safe for a growing child's body. The article presents an overview of publications on clinical studies of combined bioregulatory drugs (CBD) ­Viburcol, Engystol, Lymphomyosot, Lymphomyosot H by German company Biologische Heilmittel Heel GmbH (hereafter - Heel company), which are widely used in childhood diseases [1-3, 4-9, 11-26]. Scientific and clinical studies show the high efficacy of these drugs, which in some cases is comparable with that of other drugs [4-8]. At the same time, above mentioned CBD have a favorable safety profile and are well tolerated by children [4-9, 11-26]. 
546 |a EN 
546 |a UK 
690 |a Viburcol 
690 |a Engystol 
690 |a Lymphomyosot 
690 |a Lymphomyosot H 
690 |a bioregulatory approach 
690 |a combined bio­regulatory drugs 
690 |a childhood diseases 
690 |a Pediatrics 
690 |a RJ1-570 
655 7 |a article  |2 local 
786 0 |n Zdorovʹe Rebenka, Vol 11, Iss 6.74, Pp 51-55 (2016) 
787 0 |n http://childshealth.zaslavsky.com.ua/article/view/82131 
787 0 |n https://doaj.org/toc/2224-0551 
787 0 |n https://doaj.org/toc/2307-1168 
856 4 1 |u https://doaj.org/article/d2ef2c07aaad4e18bcc9c8037b3e0e62  |z Connect to this object online.